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Two structural proteins form the Papillomavirus (PV) capsids. While the functions of the major structural protein L1 are well
established, the exact functions for the minor structural protein L2 are much less well defined, except for some information
on a role in viral entry and maturation of infectious virions. To gain more insight in the function of L2 we used the yeast two
hybrid system with the Human Papillomavirus (HPV) 11 L2 and HPV16 L2 as bait proteins to isolate putative cellular
interaction partners. We identified four proteins interacting with L2 proteins of at least two different HPV types and this
interaction was confirmed in vitro by pull-down assays. Further evidence for this interaction was obtained by in vivo
localization studies. Two of the proteins, the previously described PATZ and a novel protein, designated PLINP, were localized
in discrete nuclear domains and colocalized with L2. The third protein, designated PMSP, is a newly identified cytoplasmic
protein which was recruited to nuclear dots when coexpressed with L2. The fourth protein interacting with HPV16, 11 and
1 L2, the tubular-nephritis antigen related protein (TIN-Ag-RP), shows a cytoplasmic as well as a membrane bound
subcellular distribution. Taken together, our data indicate that L2 of HPVs with different phenotypes interacts with several
cellular host proteins, recruits one of them to the nucleus, and is complexed with at least three cellular proteins in specific
nuclear domains. These findings suggest an HPV type-independent modulatory function of L2 on host-cell functions that
involves discrete nuclear domains and alteration of the subcellular distribution of cellular proteins. The interacting cellularINTRODUCTION
Human papillomaviruses (HPV) are epitheliotropic vi-
ruses found in a large number of different vertebrates.
The virus life cycle is tightly connected to the differenti-
ation program of the infected stratified epithelium and
due to this fact papillomaviruses cannot be efficiently
produced in vitro (Stubenrauch and Laimins, 1999). Over
one hundred different Papillomavirus types infecting hu-
mans have been identified, causing both, benign and
malignant diseases (zur Hausen, 2001). The organization
of the viral genome is highly conserved between the
different Papillomavirus types. Papillomaviruses possess
an icosahedral capsid of a T  7 symmetry composed of
the major structural protein L1 and the minor structural
protein L2 in addition to the viral genome coated by
cellular histones (Baker et al., 1991). It has now been well
established, that the L1 protein alone self assembles into
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dressed. Fax: 49 6221 424902. E-mail: Martin.Mueller@dkfz.de.69virus-like particles (VLPs) in a number of different exper-
imental systems. These particles bind to a receptor mol-
ecule present on the surface of many different cell types
and there is no indication that different Papillomavirus
types bind to different receptor molecules (Mu¨ller et al.,
1995; Roden et al., 1994a). The exact role of the viral
minor structural protein L2 is, however, less clear. While
360 L1 molecules are present in a virion, it has been
estimated that there are only 12 L2 molecules. It has
been assumed that these L2 molecules are located in
the center of the twelve pentavalent capsomers in the
capsid (Trus et al., 1997). There have been reports that L2
is required for the generation of infectious virions or
pseudovirions and that L2, in addition to L1, interacts
with a cell surface receptor (Kawana et al., 2001; Okun et
al., 2001). In fact, part of the L2 protein present in the
virions extends to the surface of the viral particles and is
a target for neutralizing antibodies. These antibodies,
however, do not interfere with attachment of the virions
to the cell surface (Liu et al., 1997; Roden et al., 1994b).
In addition to a role of L2 in the entry pathway of the
papillomaviruses, the L2 protein might be a key factor
during assembly and maturation of the viruses. Whenproteins identified may play a role in the viral life cycle an
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dots that have been identified as promyelocytic leukemia
oncogenic domains (PML-oncogenic domains or PODs,
PML bodies, ND10) (Day et al., 1998). These nuclear
domains are defined by the presence of a number of
cellular proteins, the best characterized is the PML pro-
tein itself (Maul et al., 2000). Although the exact functions
of PODs in cells are yet undetermined, they appear to
play an important role in several cellular processes in-
cluding transcriptional regulation. The latter is evident for
instance by the fact that several transcription factors are
transient or permanent components of PODs (Sternsdorf
et al., 1997). Although it has yet to be determined why the
L2 protein targets PODs, an involvement in the assembly
process of papillomaviruses has been hypothesized in
which L2 recruits other viral components such as L1 and
E2 to PODs. Since the E2 protein is the only viral protein
that is able to specifically recognize the viral DNA, the
hypothesized assembly of PV capsids would explain how
the preferential packaging of the viral DNA is accom-
plished.
To further elucidate L2 functions in infected cells, we
performed a yeast two hybrid screening with HPV16 and
HPV11 L2 as baits. We identified a number of different
putative interaction partners for L2. Some of the identi-
fied cellular proteins interacted with the L2 proteins of
two or three different HPV types (HPV11, HPV16, and
HPV1) implicating a conserved function in the viral life
cycle.
RESULTS
Identification of candidate interaction partners of
HPV11 and HPV16 L2
To identify cellular proteins that interact with the HPV
minor capsid protein L2 we performed yeast two hybrid
screenings of a human keratinocyte cDNA library con-
taining 2.5  106 independent clones. Two independent
screenings were initiated using either HPV11 L2 or
HPV16 L2 as baits. Upon transformation of yeast cells
with the bait and the library expression constructs in
each of the two screenings, a large number of colonies
on selective minimal medium (H-A-L-T3AT) were ob-
tained. Yeast colonies from these initial transformations
were repeatedly plated on selective medium to confirm
the His and Ade phenotype. From the candidate
clones obtained with HPV11 L2 as a bait, 56 out of 85
were confirmed after 3 rounds of replating on selective
media. These candidates were further assayed for
strength of interaction by using a -galactosidase re-
porter gene assay. 38 clones with potentially strong HPV
L2 affinity (-gal activity 15 units) were found (Fig. 1A).
Upon retesting the 38 cDNAs by retransformation in
yeasts carrying either the HPV11 L2-bait vector, the
empty bait vector or a bait vector encoding the retino-
blastoma susceptibility protein (p107), respectively, 9
clones expressing proteins interacting with HPV11 L2
remained (Table 1). An analogous screening performed
for HPV16 L2 interacting proteins resulted also in iden-
tification of nine cDNAs coding for candidates (Table 1
and Fig. 1B) which fulfilled the criteria given above.
Sequence analysis of potential common and HPV
type-specific L2 interaction partners
The cDNAs of the 18 prey plasmids obtained by
screening with the HPV11 L2 and HPV16 L2 bait plasmid
were subsequently sequenced, and a BlastN search of
Genbank with the DNA sequences was performed. Thir-
teen of 18 clones were identified as gene products de-
scribed previously, and five clones were identified as yet
uncharacterized entries (‘cDNA’) in the Genbank library
(Table 1). Notably, several of the 18 cDNAs encoded
independent clones of the same protein (Table 1). For
example, the Tip60 gene is represented by 3 indepen-
dent clones (No. 553, No. 559, No. 575) interacting with
HPV16 L2 in the yeast system. Furthermore, a G-protein
-subunit was found twice (No. 40 and No. 47) in the
screening with HPV11 L2 as a bait and once in the
screening using HPV16 L2 as a bait (No. 76). These data
as well as the low expression levels of these proteins in
cells argue for the selectivity and specificity of our
screening procedure.
In order to maximize the chance of having isolated
interaction partners of HPV L2 proteins even further, we
also analyzed whether any of the 18 prey proteins iden-
tified with the HPV16 or HPV11 L2 bait is able to interact
with L2 from three different HPVs (HPV1, HPV11, and
HPV16). These types represent the different tropism and
pathogenic potential found among the human papilloma-
viruses. Upon transformation of the corresponding plas-
mids into yeast, 3 of the 18 prey plasmids (No. 10, No. 44,
No. 557) tested generated colonies and were positive in
the o-NPG assay, indicating that the corresponding 3
proteins interact with the L2 protein of at least 2 different
papillomaviruses. Comparison of the cDNAs isolated
with the L2 proteins of HPV11 and HPV16 indicates 1
potential common interacting candidate (No. 16) which
did, however, not bind to HPV1 (Table 1A). Therefore,
there may be cellular proteins which bind to L2 proteins
of most, if not all HPV types and others which are more
selective. Given the rather high sequence divergence of
L2 proteins, different pathogenic potentials, and differ-
ences in the tropism of various HPVs on the one hand
and a likely common function of L2 proteins in the life
cycle of all HPVs on the other hand, this is well conceiv-
able. In the following we describe the sequence features
and functional analysis of only those cellular proteins
identified in the yeast two hybrid which appear to interact
with at least two different L2 proteins (clones No. 10, No.
16, No. 44, No. 557), and, therefore, are more likely to
shed light on HPV type-independent functions of the L2
protein in the viral life cycle.
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Two of the cDNAs (No. 10 and No. 557) code for
proteins described previously. cDNA No. 10 contains the
partial sequence (amino acids 160–380) of the 59 kDa
PATZ protein (POZ/BTB-AT-hook-zinc finger protein) re-
ported to be a nuclear protein with trans-repressive func-
tions which interacts with RNF4 (RING-finger protein), a
co-regulator of the androgen receptor-dependent tran-
scription (Fedele et al., 2000). The PATZ protein is ex-
pressed at low levels in all tissues examined so far, with
particular high expression in human testis. The partial
sequence of the PATZ cDNA isolated here comprises the
DNA-binding AT-hook motif, two of the four zinc-finger
motifs as well as both nuclear localization signals iden-
tified by Fedele et al., but is lacking the N-terminal BTB/
POZ domain, a protein–protein–interaction interface. As
the RNF4 interacting clones described by Fedele et al.
overlap in the region around the AT-hook, the polypeptide
encoded by cDNA No. 10 might very well represent an
additional protein–protein–interaction domain. Interest-
ingly, Fedele et al., localized PATZ in a nuclear dot-like
structure similar to the PODs, where the BPV1 L2 was
found in a previous report.
cDNA No. 557 represents a partial sequence of TIN-
Ag-RP (tubulointerstitial nephritis antigen related protein)
(Bro¨mme et al., 2000), a protein of the extracellular matrix
related to cathepsin B proteases. Unlike cathepsin, TIN-
Ag-RP has no proteolytic activity due to a single amino
acid exchange in the catalytic domain (C 3 S) and
beyond that little is known about its function. The full-
length protein has a calculated molecular weight of 55
kDa. The protein is moderately expressed in almost all
tissues examined, particularly in vascular smooth mus-
cle cells and other muscle types, and no expression was
detected in hematopoetic cells (Wex et al., 2001).
cDNA No. 16 codes for a so far unknown protein with
a calculated molecular weight of 25.4 kDa. Based on its
interaction with both the HPV16 L2 and HPV11 L2 protein
in the yeast system we propose the designation “Papil-
FIG. 1. o-NPG assay: Interaction of L2 and the prey proteins in the yeast system determined by -galactosidase activity. A: HPV11 L2; B: HPV16
L2. The cut-off value for strong interaction was arbitrarily set at 15 units (HPV11 L2) and 12 units (HPV16 L2) respectively. Clones interacting with both
L2 proteins display a -galactosidase activity similar with both L2 types except for No. 16 that activates -galactosidase much stronger together with
HPV16 L2 compared to HPV11 L2. Numbers are indicating clones that were positive in the back-transformation experiments and included in further
analysis. At least two independent experiments were performed resulting in comparable -galactosidase activities of the various clones. The error
bars shown represent the standard deviation of one of the experiments using a triplicate assay setup.
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lomavirus L2 interacting nuclear protein” (PLINP; EMBL
Database Submission AJ429498). The DNA sequence of
cDNA No. 16 has a 99% identity with a 708 bp-long cDNA
derived from a choriocarinoma (Genbank Accession No.
BG479195) and only slightly lower sequence identity (up
to almost 99%) with additional entries. The correspond-
ing genomic sequence is located on chromosome
19p13.2 (Accession No. HSAD92). The Genbank entries
reveal PLINP mRNA to be expressed ubiquitously as it
was detected in normal and tumorous human tissue/
cells derived from brain, lung, skin, muscle, testis,
spleen, and eyes. PLINP sequences of the mouse and
rat homologue (partial sequence) are present in the da-
tabases (Accession Nos. AK019570 and AI411436). Com-
parative analysis revealed a high level of sequence sim-
ilarity (77.5% similarity and 73.9% identity) between the
human and mouse PLINP protein. No significant similar-
ities to other proteins were found using BLASTP2
searches of databases. For the human polypeptide only
low similarities for a subsequence of PLINP (in a stretch
of 71–82 amino acids) to other proteins were found,
among them the hypothetical protein DKFZp434A025.1
(Accession No. T46481, 35% identity), a mouse serine
threonine kinase (Accession No. T30989; 35% identity)
and a human translation initiation factor IF2 homologue
(or hypothetical protein DKFZ p434I036.1, Accession No.
T43483, 31% identity). Since the similarities were not
found in defined clusters, the database analysis does not
provide additional information about putative functional
domains of PLINP. Analysis of the human PLINP
polypeptide revealed no significant motifs or domains,
except for a potential nuclear localization sequence
(NLS; aa184–aa199). However, this potential NLS is ab-
sent in the rodent PLINP proteins arguing against its
function or for a species–specific function.
Neither an identical nor a related peptide sequence entry
has been found for cDNA No. 44 which codes for a 61 aa
long protein (7.4 kDa). Also a PROSITE scan did not reveal
any known protein motif or domain. This protein—interact-
ing with at least 3 HPV subtypes—was designated PMSP
TABLE 1
Potential Interaction Partners of HPV11 L2 (A) and HPV16 L2 (B)
A
cDNA
clone
Interaction with L2 protein of GenBank
Accession
No. Corresponding protein
Amino acids encoded/aa
of full-length proteinHPV16 HPV11 HPV1
No. 10    AF119256 PATZ (POZ-AT-Zn-finger) 160–380/540
No. 16    BG479195 Uncharacterized cDNAa 1–222/222
No. 25    AF286886 Uncharacterized cDNA 220
No. 40    M16514 G-protein, -subunit 1–340/340
No. 44    D88650 Uncharacterized cDNAb 1–60/60
No. 46    AK026534 Ferritin LCd 1–174/174
No. 47    M16514 G-protein, -subunit 1–186/340
No. 59    AI263475 Uncharacterized cDNA 290
No. 79    U60266 Lysosomale -Mannosidase 751–1011/1011
B
cDNA
clone
Interaction with L2 protein of GenBank
Accession
No. Corresponding protein
Amino acids encodede/aa
of full-length proteinHPV16 HPV11 HPV1
No. 553    U74667 Tip60 (tat interacting protein) 81–242/513c
No. 554    AK023983 AUP1 (ancient ubiquitous pr.) 160/371
No. 557    AF236150 TIN-Ag-RP 339–467/467
No. 558    L10379 Uncharacterized cDNA 130
No. 559    U74667 Tip60 114–353/513
No. 569    D89667 c-myc-modulating protein 9–167/167
No. 574    Z66539 Creatine-transporter (CRTR) 579–635/635
No. 575    U74667 Tip60 185–350/513
No. 580    AF032986 Serine-threonine-kinase 11 /431
No. 76    M16514 G-protein, -subunit 162–340/340
Note. The proteins listed in the table were identified as potential L2 interaction partners in the yeast two hybrid system. Interactions with more than
one L2 protein (HPV1, HPV11, and HPV16) are indicated as well as the identity of the clone (GenBank Accession No. of the most similar cDNA, identity
of the corresponding protein and length of the polypeptide encoded by the cDNA, if possible). Interaction of clone No. 79 with HPV 16 L2 in the yeast
transformation assays yielded inconsistent results.
a We named No. 16 PLINP; EMBL database submission AJ429498.
b We named No. 44 PMSP; EMBL database submission AJ437509.
c Splice variant: Amino acids 95–148 are missing.
d Typical false positive interaction in the yeast two hybrid system.
e For those clones that were sequenced in full.
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(Papillomavirus minor structural protein interacting protein,
EMBL Database Submission AJ437509).
All four proteins expressed from the cDNA as GST-
fusion proteins bind in vitro to recombinant HPV16 L2
To provide independent additional evidence for inter-
action between the proteins encoded by the cDNAs
isolated and HPV16 L2 observed an in vitro binding
assay was performed (Fig. 2). For this, a GST pulldown
experiment was performed using GST-fusion proteins of
the different cDNAs and a lysate of insect cells previ-
ously infected with a recombinant baculovirus encoding
the HPV16 L2 protein. The proteins eluted from the
sepharose in the pulldown experiment were separated
by SDS–PAGE and then analyzed by Western blotting
using a HPV16 L2-specific polyclonal antiserum. As
shown in Fig. 2, the 72 kDa HPV16 L2 is specifically
retained on the column loaded with the GST-fusion pro-
teins, but not with the GST negative control. This pro-
vides further evidence for the interaction of HPVL2 with
all four cellular candidate proteins.
Intracellular localization of PLINP, PATZ and Tin-Ag-RP
To determine the subcellular localization of the L2-
interacting proteins in mammalian cells, the cDNAs were
inserted in the pEGFP-C3 expression vector. Lysates of
transfected cells were analyzed by western blotting us-
ing an anti-GFP-antibody to verify that the expressed
fusion proteins were of the expected sizes (data not
shown). To analyze the intracellular localization of the
proteins encoded by the four cDNAs 911 cells (human
retina cell line) were transfected with the pEGFP-vectors
expressing PLINP, PMSP, PATZ, and TIN-Ag-RP as EGFP-
fusion proteins (Figs. 3–5). Similar experiments were
carried out using CV1 cells (African green monkey kidney
epithelial cells) and Hela cells (human cervical carci-
noma cell line), however, no cell type specificity of sub-
cellular localization of the L2 interacting proteins was
observed in these cells.
It has been previously reported that, upon expression
in cells using the Semliki Forest Virus expression sys-
tem, the bovine papillomavirus type 1 L2 protein localizes
in distinct nuclear domains, the PML-oncogenic domains
(PODs) (Day et al., 1998). A pattern consistent with local-
ization of L2 to PODs was also observed when 911 cells
were transfected with the UF3-HPV16-L2h construct cod-
ing for an L2 protein that was codon optimized for ex-
pression in human cells (Fig. 3E). The EGFP-fusion pro-
teins were coexpressed with HPV16 L2 to determine
whether the subcellular localization confirms the pro-
tein–protein interaction observed in the yeast system
and the pulldown experiment (Figs. 3 and 4).
The extracellular matrix protein TIN-Ag-RP-EGFP pro-
tein was found cytoplasmically and membrane-bound
with two different distinct staining patterns (Fig. 5). While
the majority (more than 90%) of the transfected cells
demonstrated a rather homogenous cytoplasmic distri-
bution of the exogenous TIN-Ag-RP (Fig. 5A), in less than
ten percent of cells TIN-Ag-RP accumulated in large
cytoplasmic lumps (Fig. 5B). Co-expression of HPV16 L2
with TIN-Ag-RP did partially change the localization of
both proteins. In cells containing cytoplasmic lumps of
TIN-Ag-RP, L2 protein was efficiently excluded from the
nucleus as considerable fractions of TIN-Ag-RP and L2
were found in these cells in a perinuclear region where
both proteins colocalized. In rare occasions TIN-Ag-RP
was found colocalized together with L2 in nuclear dots
(Fig. 5C, one cell). Although this unusual staining pattern
of TIN-AG-RP could be a result of the protein overexpres-
sion, these results argue for L2/TIN-Ag-RP interaction in
higher eukaryotic cells, however, in most of the cells L2
localized to the nucleus and TIN-Ag-RP was associated
with the cellular membrane or homogenously distributed
in the cytoplasm (Figs. 5A and C).
FIG. 2. In vitro interaction of HPV16 L2 with putative interaction partners. To determine in vitro interaction of L2 with the proteins identified in the
screening a GST pulldown experiment was performed. The amount of L2 protein remaining on the column loaded with the various GST fusion proteins
was determined by Western blot using a polyclonal rabbit--HPV16 L2 serum (1:2000) and goat--rabbit-peroxidase (1:4000). L2 interacts with
GST-PATZ, GST-PLINP, GST-PMSP, GST-No. 79 and GST-TIN-Ag-RP but not with GST (A). In comparison to PLINP a GST-tat-protein was analyzed as
additional negative control (B).
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FIG. 3. Subcellular localization of PLINP and HPV16 L2. 911 cells were transfected with the EGFP-PLINP-expression vector (A–D) or histone H1-GFP-
(F) and EGFP- (G) expression plasmids respectively and the HPV16 L2-expression vector pUF3-L2 (B–G). The cells were fixed two days after
transfection and stained for HPV16 L2 (polyclonal rabbit--HPV16 L2 serum/goat--rabbit-Cy3 or goat--rabbit-FITC respectively (in E)). Samples were
subsequently analyzed by confocal microscopy. EGFP-PLINP (green) localizes in nuclear dots (A). After coexpression of HPV16 L2 (red) a
colocalization of the two proteins can be observed (B–D). HPV16 L2 (green) is localized in nuclear dots after expression in mammalian cells (E). As
controls L2 (red) was coexpressed with histone H1-GFP and EGFP (green in F  G), which does not result in a colocalization of these proteins.
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In contrast to the TIN-Ag-RP-EGFP fusion protein,
PLINP–EGFP localized exclusively in nuclei and predom-
inantly concentrated in dot-like structures (Fig. 3A), in-
distinguishable from that seen with L2 alone (Fig. 3E). To
determine whether indeed PLINP and L2 colocalize to
the same subnuclear domains, we cotransfected cells
with the EGFP–PLINP and the L2 expression construct.
An almost perfect colocalization of the two proteins in
nuclear dots was found (Fig. 3B–D) with virtually all
EGFP–PLINP protein residing in nuclear dots and only a
small portion of the PLINP-specific signal in the nucleo-
plasm. This finding strongly argues for an in vivo inter-
action of PLINP and HPV16 L2.
To demonstrate specificity of the observed colocaliza-
tion and to exclude the possibility that any colocalization
seen was due to the EGFP portion of the fusion protein,
we cotransfected cells with HPV16 L2 and either the
EGFP-expression vector construct (unfused EGFP) or a
construct encoding a GFP-histone H1 fusion protein
(kindly provided by A. Alonso, DKFZ Heidelberg). Neither
the EGFP nor the EGFP-histone H1 protein localized
alone in dot-like structures nor did they colocalize with
HPV16 L2 (Fig. 3F and G) indicating the specificity of the
colocalization data described above.
The cellular PATZ protein (corresponding to protein
encoded by cDNA No. 10) has been previously described
to localize to nuclear dots. However, it was not reported
so far to which type of nuclear domain they correspond
nor whether there is any relation with papillomavirus L2
proteins. Therefore, we analyzed in cells cotransfected
with EGFP–PATZ and HPV16 L2 expression vectors
whether these two proteins are recruited into the same
domains. In fact, a high degree of colocalization of L2
and PATZ in nuclear dots was observed (Fig. 4E and F).
Intracellular localization of PMSP is altered by
coexpression of HPV16 L2
Expression of the PMSP protein revealed an exclusive
or at least predominant cytoplasmic localization in trans-
fected 911 cells although the predicted size of PMSP–
GFP would still allow passive entry into the nucleus (Fig.
4A). Unexpectedly, upon co-expression with HPV16 L2
the cytoplasmic location of EGFP–PMSP changed dra-
matically, a substantial portion of the PMSP protein was
recruited to nuclear dot-like structures where it colocal-
ized with L2 (Fig. 4B–D) suggesting the interaction of L2
and PMSP in mammalian cells.
Together, the transfection studies in higher eukaryotic
cells and immunofluorescence analysis provide strong
and independent additional evidence that all four cellular
proteins encoded by cDNAs isolated by the yeast two
hybrid-screenings interact with HPV L2 proteins and are
in part even altered in their intracellular locations.
DISCUSSION
In recent years several studies suggested a role for
the minor capsid protein L2 at different stages of the
papillomavirus life cycle (Day et al., 1998; Kawana et al.,
2001; Liu et al., 1997; Roden et al., 1994b, 2001). The aim
of this study was to gain more insight into this through an
analysis of virus-host interaction by identifying cellular
interaction factors of the L2 protein. Among the potential
interacting cellular proteins isolated by yeast two hybrid
screenings, we focused on those clones that were pos-
itive for interaction with L2 proteins of more than one
papillomavirus type. This strategy promised to reveal
functions of L2 common to different HPV types and to
reduce the chance of identification of false positive in-
teraction partners during the screening and analysis. We
identified four cellular proteins which interact with L2
proteins of different HPV types in yeast. The specificity of
the interactions of L2 with the proteins PLINP, PMSP,
PATZ, and TIN-Ag-RP was further corroborated by their in
vitro interaction with HPV16 L2. Importantly, the subcel-
lular distribution, of these cellular proteins, expressed as
GFP fusion proteins, determined in presence and ab-
sence of HPV16 L2 in higher eukaryotic cells revealed a
reproducible colocalization of these proteins with L2.
This strongly argues that these proteins interact with L2
also in mammalian cells.
For PATZ, a localization to nuclear dots has previously
been reported, similar to that of the L2 protein (Fedele et
al., 2000). Here we have demonstrated for the first time
by colocalization experiments that the dots formed by
both proteins are in fact identical. This confirms that the
interaction of the two proteins seen in the yeast system
and in the in vitro assay can also take place in mamma-
lian cells. PATZ, a transcriptional regulator and member
of the zinc finger proteins, has been originally identified
as an interactor for the androgen receptor, a nuclear
hormone receptor (Fedele et al., 2000; Pero et al., 2001).
Since HPV persists in host cells and induces generation
of papillomas, one might speculate that the L2-PATZ
interaction plays a role in gene regulation and cell de-
FIG. 4. Subcellular localization of HPV16 L2 and PMSP (A–D) and PATZ (E–F). Fluorescence microscopy analysis was performed as described in
figure 3. EGFP-PMSP (green) is localized in the cytoplasm when expressed alone (A) but colocalizes with HPV16 L2 (red) in nuclear dots upon
coexpression (B–D). EGFP-PATZ (green) is localized in nuclear dots (E) and is colocalized with HPV16 L2 upon coexpression (D).
FIG. 5. Subcellular localization of TIN-Ag-RP. Recombinant EGFP-TIN-Ag-RP (green) is mostly distributed homogenously in the cytoplasm or on the
cell surface (A), but can also be found in cytoplasmic lumps (B). Homogenously distributed TIN-Ag-RP displays no overlapping with coexpressed
HPV16 L2 (red in C). Cytoplasmic accumulated TIN-Ag-RP in contrast, colocalizes with HPV16 L2 in the cytoplasm (D–F). Fluorescence microscopy
analysis was performed as described in Fig. 3.
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differentiation, which are both associated with papilloma
formation.
TIN-Ag-RP is a protein of the extracellular matrix and
may therefore interact with the virion-embedded L2 pro-
tein during the early phase of infection. Alternatively or in
addition, the partial colocalization of recombinant EGFP-
TIN-Ag-RP and L2 observed in some cells indicates that
these two proteins can interact also intracellularly. If
these extracellular as well as intracellular interactions
take place in a natural infection process, our findings
may imply that TIN-Ag-RP plays a role both in papilloma
virion cell attachment and in intracellular trafficking of
viral proteins or viral particles.
The yet uncharacterized protein PMSP was found in
the cytoplasm when expressed as an EGFP fusion pro-
tein. In contrast, when coexpressed with HPV16 L2 the
PMSP was predominantly found in the nucleus where it
colocalized with L2 in nuclear dots. These observations
together with the pull-down and yeast two hybrid data
suggest that both proteins bind directly to each other in
the cytoplasm and thus the PMSP is recruited into the
nucleus with or without the help of other cellular pro-
teins. It will be interesting to investigate why this change
of subcellular localization of the cellular protein takes
place and whether this modulates host cell function
and/or virus infection. Elucidation of the cellular function
of PMSP which is unknown so far will be essential to
uncover its role for the viral life cycle. A similar reasoning
applies to the PLINP protein for which there is so far no
hint as to its function. However, the high sequence con-
servation of this protein in the various mammalian spe-
cies analyzed and its expression in virtually all human
tissues and organs argues for an important function of
PLINP which is worth to be defined. This protein is also
interesting for other reasons. First, it is almost exclu-
sively localized in PODs or closely adjacent bodies. Sec-
ond, the only potential NLS sequence found in human
PLINP by sequence analysis is not functional according
to experiments with PLINP deletion mutants (data not
shown) and this is also corroborated by the lack of a
corresponding NLS sequence in the mouse PLINP.
Therefore, PLINP has either a nonconventional NLS or it
is recruited to the nucleus by another cellular protein.
Ongoing mutational analysis of PLINP and identification
of cellular interaction partners will differentiate between
these two possibilities.
To determine whether nuclear dots formed by HPV16
L2, PLINP, PATZ and PMSP are in fact PODs, as it was
demonstrated for the BPV1 L2 protein earlier, we per-
formed colocalization studies using the PML protein as a
marker for PODs. Results indicated that the four proteins
do not always colocalize with PML but are frequently in
close association with PODs. This may indicate a differ-
ence between L2 of bovine and human papilloma vi-
ruses. Alternatively, this may be due to differences in the
cell types and experimental conditions used. This is well
conceivable if one considers known differences in num-
ber, size and shape of PODs in various cells as well as
the dynamic nature of the POD structure and composi-
tion. Detailed ongoing studies including electron micro-
scopic examinations will reveal how closely and often L2
is associated with or localized in PODs and which of the
known components are involved in its recruitment to
specific subnuclear domains. Independent of the open
questions as to the relevance of the precise localization
of the proteins identified and their role for the HPV life
cycle our study has uncovered novel cellular compo-
nents of nuclear domains and thus contributes a re-
search field with increasing importance in general and
for virus infections in particular.
MATERIAL AND METHODS
Bacterial strains
For selection of the pACT-plasmids isolated from yeast
the leucine auxotroph Escherichia coli LeuBHB101
strain was used. Plasmid propagation was performed in
E. coli DH5. Recombinant GST-fusion proteins were
expressed in the E. coli BL21(DE3) strain.
Yeast strains
For the yeast two hybrid experiments S. cerevisiae
PJ596 bearing the Gal4 promoter-dependent selectable
markers HIS3, lacZ, and ADE2 was used. The mainte-
nance of the yeast cells followed standard procedures
as described in the manufacturer’s yeast two hybrid
screening manual (Clontech, Palo Alto, CA).
Protein expression in insect cells
Production and propagation of HPV16 L2-recombinant
baculoviruses was performed in Sf9 insect cells in
TNM-FH media supplemented with 10% fetal calf serum
according to manufactures recommendations (Novagen,
Darmstadt, Germany). For expression of the protein 250
ml of a H5 cell suspension culture at a density of 1–2 106
cells/ml were infected by recombinant virus at a MOI of
2–5 for three days. The cells were maintained in serum
free medium (Excell 405, JRH Bioscience, Lenexa, Kan-
sas) at 27°C. Infected cells were harvested by centrifu-
gation at 5000 rpm for 10 min. Pellets of a 250 ml culture
were resuspended in 5 ml buffer IV (20 mM Hepes (pH
7.2); 200 mM potassium acetate; 2 mM magnesium ac-
etat; 0.5% Tween 20; 1 mM dithiothreitol) with a protease
inhibitor cocktail (Complete Roche, Mannheim, Ger-
many) and sonicated with medium intensity. Cleared
lysates were obtained after centrifugation at 10000 rpm
for 15 min at 4°C. The lysates were used immediately for
pull down experiments.
Mammalian cells
To analyze interaction of HPV16 L2 with cellular pro-
teins the following mammalian cell lines were used:
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HeLa (ATCC CCL-2; human cervical carcinoma cells), 911
(human retina cells (Fallaux et al., 1996)), 293T cells
(human embryonic kidney cells). Cells were maintained
in DMEM/10% FCS following standard procedures. For
transfection, 1  106 cells per 10 cm culture dish were
seeded on cover glasses and cultivated overnight. Trans-
fection was performed overnight using a calcium phos-
phate precipitation protocol as described previously
(Chen and Okayama, 1987). After replacement of the
medium, cells were further incubated at 37°C for 40 h
after transfection.
Plasmid construction
Yeast expression vectors. For the yeast two hybrid
screening HPV16 L2, HPV11 L2 or HPV1 L2 were ampli-
fied by PCR and then cloned into the pAS2-1 vector
(Clontech) via NcoI and EcoRI/BamHI/SmaI sites: HPV11
L2forward: 5-TTT TCT AGA CCA TGG GCC CTA GGG
CAC GCA GAC GTA AAC GTG GCT CA-3; HPV11
L2reverse: 5-TTT GAA TTC CTG TGC TGT CGC TAG
GCC GCC GCC ACA-3; HPV1 L2forward: 5-TTT GAA
GCT TCC ATG GCC ACC ATG TAT CGC CTA CGT AGA
AAA C-3; HPV1 L2reverse: 5-TTT GGA TCC TTA TAC
ATA AGC TCT TTT ACG ACG CTT-3; HPV16L2forward:
5-TTT TCC ATG GGA CAC AAA CGT TCT GCA AAA CGC
ACA AAA CGT GCA TC-3; HPV16L2reverse: 5-TTT TCC
CGG GGG CAG CCA AAG AGA CAT CTG AAA AAA
AAT-3.
Bacterial and mammalian expression vectors. The
cDNAs identified in the screenings were subsequently
inserted into the pGEX-4T2 expression vector (GST fu-
sion proteins; Amersham Pharmacia) and into the
pEGFP-C3 vector (GFP-fusion proteins; Clontech). In-
stead of cDNA No. 557 the full length clone Tin-Ag-RP
(kindly provided by T. Wex, University of Magdeburg) was
inserted into pEGFP-C3. For expression of HPV16 L2 in
mammalian cells a codon-optimized variant of the L2
gene inserted into the pUF3 expression vector was used
(Leder et al., 2001).
Detection of recombinant proteins
For detection of HPV16 L2 a polyclonal rabbit serum
(No. 20) was used (dilution for Western-blot analysis:
1:2000, for immunofluorescence detection: 1:200). EGFP
fusion proteins were detected by autofluorescence or by
using a monoclonal mouse anti GFP antibody (Santa
Cruz; 1:2000 in Western blot analysis). As secondary
antibodies for Western-blot analysis horse radish perox-
idase conjugated goat anti-rabbit- or goat anti-mouse-
antibodies (Sigma) were used. For immunofluorescence
staining goat-anti-rabbit-Cy3, goat-anti-rabbit-FITC and
goat anti-mouse-Cy3 conjugates were used (Dianova).
Yeast two-hybrid screening
Yeast cells were maintained and manipulated accord-
ing to standard protocols. The yeast two hybrid screen-
ing was performed as described previously (Fields and
Song, 1989) and according to the manufacturer’s instruc-
tions (Clontech). The yeast strain PJ596 was transformed
with the pAS2-1 plasmid constructs containing the
HPV16 L2 or HPV11 L2 gene as baits. Transformants
were selected and cultivated on minimal medium lacking
tryptophane. The cells were subsequently transformed
with a HaCat-cDNA expression library (Clontech) in the
pACT2-plasmid. This cDNA library had a complexity of
2.5  106 independent clones. After initial selection and
repeated re-streaking on SD minimal medium lacking
histidine, adenine, leucine, and threonine containing 4
mM 3AT (3-aminotriazole) the selected clones were fur-
ther analyzed for -galactosidase activity by a liquid
culture o-NPG assay as described by the manufacturer.
The plasmid DNA from positive clones was isolated and
used to transform the E. coli LeuB-HB101 strain which
allows selection for the pACT2 plasmids. The cDNA
clones were isolated from bacteria growing on minimal
medium containing ampicillin and lacking leucine. The
plasmids were retransformed into yeast cells containing
pAS2-1-HPV16 L2 or -HPV11 L2, as well as into yeast
cells containing the empty pAS2-1 plasmid or a pAS2-1-
p107 plasmid as negative controls. Those cDNAs that
allowed growth of pAS-2-HPV L2 harboring yeast cells in
minimal medium but not growth of yeast cells harboring
the empty plasmid were further analyzed by DNA se-
quencing. Additionally, these HPV16 L2- and/or HPV11
L2-interacting clones were tested for their interaction
with HPV1 L2 in the yeast system.
Expression and purification of GST-fusion proteins
The GST-cDNA fusion constructs (pGEX-4T2, Amer-
sham Pharmacia, Freiburg, Germany) were expressed in
E. coli BL21(DE3). Medium was inoculated with 1/20
volume of a fresh overnight culture and incubated at
25°C until an O.D.600 of 0.5–0.8 was reached. After addi-
tion of 100 M IPTG (isopropylthiogalactoside) for induc-
tion of the inducible lac-promoter the bacteria were cul-
tured for 3 h. The cultures were harvested by centrifuga-
tion and washed once with phosphate buffered saline
(PBS). Pellets were resuspended in buffer IV and soni-
cated twice for 30 seconds at 2/3 of maximum intensity.
The cleared lysate obtained after centrifugation at 10,000
rpm for 15 at 4°C was loaded onto a GSTrap-column
(Amersham Pharmacia). After binding, the column was
subsequently washed with 20 volumes of buffer IV. For
elution, 5 volumes of 10 mM reduced glutathion in 50 mM
Tris–Cl pH 8.5 were used. Elution was monitored by
UV-Absorption. Peak fractions were analyzed on a Coo-
massie-Blue stained 12.5% SDS-polyacrylamide gel.
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In vitro protein binding assay—GST pull down
FPLC-purified GST-fusion proteins were dialyzed against
buffer IV and then bound to 30 l of a 50% Glutathion-
Sepharose slurry for 30 min at 4°C under moderate shak-
ing. After washing with 3 500 l buffer IV the beads were
incubated with 40l insect cell lysate containing the HPV16
L2 protein in 1 ml buffer IV for 2 h at 4°C. The supernatant
was removed subsequently and the Sepharose beads were
washed three times with 500 l buffer IV. The proteins were
eluted by addition of 30 l of 2 protein sample buffer (20
mM Tris–Cl pH 7.5, 6% SDS, 6% -mercaptoethanol, 3.5%
glycerol, 0.1% bromephenole blue) and heating to 90°C for
5 min. The samples were separated by SDS–PAGE on
12.5% gels and then analyzed by western blotting using a
polyclonal rabbit anti-HPV16 L2 antiserum.
Detection of recombinant proteins by indirect
immunofluorescence
After removal of the medium, transfected cells were
fixed with ice cold ethanol for 5 min, washed with PBS
three times and rehydrated with PBS for 10 min. The
glass cover slips with cells transfected only with expres-
sion vectors encoding for GFP-fusion proteins were em-
bedded in 50% glycerol. For immunostaining, cells were
blocked for 1 h in PBS/0.05% tween20/3% milk. The first
antibodies were added for 1 h in appropriate dilution;
after 3 washing with PBS/0.05% tween 20 secondary,
fluorescence-labeled antibodies were added for 1 h. Af-
ter washing with PBS/0.05% Tween20 the cover slips
were embedded in 50% glycerol. Samples were analyzed
by confocal laser scanning microscopy (Leica Confocal
Laser Scanning Microscope DM IRBE) using excitation
wave lengths 488 nm (GFP/FITC) and 543 nm (Cy3). The
channels were recorded separately and merged digitally.
Sequence analysis
DNA sequence analysis was done using the GCG–
HUSAR program package (DKFZ Heidelberg).
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